{"transactions":[{"id":711073,"issuer":{"id":7191,"kind":"organization","name":"Seres Therapeutics, Inc."},"owners":[{"id":30952,"kind":"person","name":"Kender Richard N","position":1,"cik":"0001381205","reported_name":"Kender Richard N","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2026-07-10T16:15:13.000Z","date":"2026-07-08","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in 36 equal monthly installments following the March 2, 2026 vesting commencement date."}],"balance_after":50000,"derivative":{"exercise_price":9.13,"expiration_date":"2036-03-03","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001193125-26-300925","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1381205/000119312526300925/ownership.xml","form_type":"4"}},{"id":855585,"issuer":{"id":7191,"kind":"organization","name":"Seres Therapeutics, Inc."},"owners":[{"id":30952,"kind":"person","name":"Kender Richard N","position":1,"cik":"0001381205","reported_name":"Kender Richard N","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2026-03-06T16:36:52.000Z","date":"2026-03-04","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and become exercisable in 36 equal monthly installments."}],"balance_after":150000,"derivative":{"exercise_price":9.13,"expiration_date":"2036-03-03","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001193125-26-096711","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1381205/000119312526096711/ownership.xml","form_type":"4"}},{"id":1085295,"issuer":{"id":7608,"kind":"organization","name":"Longeveron Inc.","symbol":"LGVN"},"owners":[{"id":30952,"kind":"person","name":"Kender Richard N","position":1,"cik":"0001381205","reported_name":"Kender Richard N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-07-17T19:44:37.000Z","date":"2025-07-15","kind":"grant","planned":false,"acquired":true,"shares":17000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the award of time-based vesting Restricted Stock Units (RSUs)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes RSUs subject to future vesting."}],"balance_after":33000,"source":{"system":"sec-edgar","filing":"0001214659-25-010568","document":"marketforms-70113.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1381205/000121465925010568/marketforms-70113.xml","form_type":"4"}},{"id":1173192,"issuer":{"id":7191,"kind":"organization","name":"Seres Therapeutics, Inc."},"owners":[{"id":30952,"kind":"person","name":"Kender Richard N","position":1,"cik":"0001381205","reported_name":"Kender Richard N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-04-11T16:05:09.000Z","date":"2025-04-10","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of April 10, 2026 or the day immediately prior to the company's 2026 annual meeting of shareholders."}],"balance_after":100000,"derivative":{"exercise_price":0.58,"expiration_date":"2035-04-09","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000950170-25-053246","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1381205/000095017025053246/ownership.xml","form_type":"4"}},{"id":1309871,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":30952,"kind":"person","name":"Kender Richard N","position":1,"cik":"0001381205","reported_name":"Kender Richard N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-01-06T19:30:10.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option shall vest in four equal installments on March 15, 2025, June 15, 2025, September 15, 2025 and December 15, 2025."}],"balance_after":12500,"derivative":{"exercise_price":14,"expiration_date":"2035-01-02","underlying":"Ordinary Shares","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001415889-25-000918","document":"form4-01062025_070106.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1381205/000141588925000918/form4-01062025_070106.xml","form_type":"4"}},{"id":1309870,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":30952,"kind":"person","name":"Kender Richard N","position":1,"cik":"0001381205","reported_name":"Kender Richard N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-01-06T19:30:10.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award. The RSUs shall vest in four equal installments on March 15, 2025, June 15, 2025, September 15, 2025 and December 15, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one ordinary share."}],"balance_after":23000,"source":{"system":"sec-edgar","filing":"0001415889-25-000918","document":"form4-01062025_070106.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1381205/000141588925000918/form4-01062025_070106.xml","form_type":"4"}},{"id":1472183,"issuer":{"id":83618,"kind":"organization","name":"Omega Therapeutics, Inc.","symbol":"OMGA"},"owners":[{"id":30952,"kind":"person","name":"Kender Richard N","position":1,"cik":"0001381205","reported_name":"Kender Richard N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-21T16:20:02.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in thirty-six substantially equal monthly installments following the date of grant, such that the option shall be fully vested and exercisable on the third anniversary of the date of grant, subject to the Reporting Person's continued service on the Issuer's Board of Directors through each such vesting date."}],"balance_after":50000,"derivative":{"exercise_price":2.2,"expiration_date":"2034-06-19","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000950170-24-076260","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850838/000095017024076260/ownership.xml","form_type":"4"}},{"id":1517087,"issuer":{"id":7608,"kind":"organization","name":"Longeveron Inc.","symbol":"LGVN"},"owners":[{"id":30952,"kind":"person","name":"Kender Richard N","position":1,"cik":"0001381205","reported_name":"Kender Richard N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2024-05-14T19:10:16.000Z","date":"2024-05-10","kind":"grant","planned":false,"acquired":true,"shares":16000,"price":1.455,"value":23280.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock units, which vest quarterly in equal installments over a period of three years, under the Company's Equity Incentive Plan."}],"balance_after":16000,"source":{"system":"sec-edgar","filing":"0001214659-24-009103","document":"marketforms-65873.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1381205/000121465924009103/marketforms-65873.xml","form_type":"4"}},{"id":1545310,"issuer":{"id":7191,"kind":"organization","name":"Seres Therapeutics, Inc."},"owners":[{"id":30952,"kind":"person","name":"Kender Richard N","position":1,"cik":"0001381205","reported_name":"Kender Richard N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-04-08T16:45:18.000Z","date":"2024-04-04","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of April 4, 2025 or the day immediately prior to the company's 2025 annual meeting of shareholders."}],"balance_after":60000,"derivative":{"exercise_price":0.76,"expiration_date":"2034-04-03","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0000950170-24-042651","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1381205/000095017024042651/ownership.xml","form_type":"4"}},{"id":1687184,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":30952,"kind":"person","name":"Kender Richard N","position":1,"cik":"0001381205","reported_name":"Kender Richard N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-01-04T18:30:25.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option shall vest in four equal installments on March 15, 2024, June 15, 2024, September 15, 2024 and December 15, 2024."}],"balance_after":12000,"derivative":{"exercise_price":18.08,"expiration_date":"2034-01-02","underlying":"Ordinary Shares","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001209191-24-000881","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1381205/000120919124000881/doc4.xml","form_type":"4"}},{"id":1687183,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":30952,"kind":"person","name":"Kender Richard N","position":1,"cik":"0001381205","reported_name":"Kender Richard N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2024-01-04T18:30:25.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award. The RSUs shall vest in four equal installments on March 15, 2024, June 15, 2024, September 15, 2024 and December 15, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one ordinary share."}],"balance_after":16750,"source":{"system":"sec-edgar","filing":"0001209191-24-000881","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1381205/000120919124000881/doc4.xml","form_type":"4"}},{"id":1844938,"issuer":{"id":7191,"kind":"organization","name":"Seres Therapeutics, Inc."},"owners":[{"id":30952,"kind":"person","name":"Kender Richard N","position":1,"cik":"0001381205","reported_name":"Kender Richard N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-23T17:21:25.000Z","date":"2023-06-22","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of June 22, 2024 or the day immediately prior to the company's 2024 annual meeting of shareholders."}],"balance_after":35000,"derivative":{"exercise_price":5.46,"expiration_date":"2033-06-21","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0000899243-23-016396","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1381205/000089924323016396/doc4.xml","form_type":"4"}},{"id":2061888,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":30952,"kind":"person","name":"Kender Richard N","position":1,"cik":"0001381205","reported_name":"Kender Richard N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-01-05T21:08:20.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":11500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option shall vest in four equal installments on March 15, 2023, June 15, 2023, September 15, 2023 and December 15, 2023."}],"balance_after":11500,"derivative":{"exercise_price":29.6,"expiration_date":"2033-01-03","underlying":"Ordinary Shares","underlying_shares":11500},"source":{"system":"sec-edgar","filing":"0001209191-23-002183","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1381205/000120919123002183/doc4.xml","form_type":"4"}},{"id":2061887,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":30952,"kind":"person","name":"Kender Richard N","position":1,"cik":"0001381205","reported_name":"Kender Richard N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2023-01-05T21:08:20.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":5750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award. The RSUs shall vest in four equal installments on March 15, 2023, June 15, 2023, September 15, 2023 and December 15, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one ordinary share."}],"balance_after":10750,"source":{"system":"sec-edgar","filing":"0001209191-23-002183","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1381205/000120919123002183/doc4.xml","form_type":"4"}},{"id":2211460,"issuer":{"id":7191,"kind":"organization","name":"Seres Therapeutics, Inc."},"owners":[{"id":30952,"kind":"person","name":"Kender Richard N","position":1,"cik":"0001381205","reported_name":"Kender Richard N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2022-07-06T19:23:32.000Z","date":"2022-07-05","kind":"grant","acquired":true,"shares":63492,"price":3.15,"value":199999.8,"ownership":{"direct":true},"balance_after":63492,"source":{"system":"sec-edgar","filing":"0000899243-22-025515","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1381205/000089924322025515/doc4.xml","form_type":"4"}},{"id":2221837,"issuer":{"id":7191,"kind":"organization","name":"Seres Therapeutics, Inc."},"owners":[{"id":30952,"kind":"person","name":"Kender Richard N","position":1,"cik":"0001381205","reported_name":"Kender Richard N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-24T16:36:03.000Z","date":"2022-06-22","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of June 22, 2023 or the day immediately prior to the company's 2023 annual meeting of shareholders."}],"balance_after":35000,"derivative":{"exercise_price":3.22,"expiration_date":"2032-06-21","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0000899243-22-024013","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1381205/000089924322024013/doc4.xml","form_type":"4"}},{"id":2221836,"issuer":{"id":7191,"kind":"organization","name":"Seres Therapeutics, Inc."},"owners":[{"id":30952,"kind":"person","name":"Kender Richard N","position":1,"cik":"0001381205","reported_name":"Kender Richard N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-24T16:32:07.000Z","date":"2022-06-22","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of June 22, 2023 or the day immediately prior to the company's 2023 annual meeting of shareholders."}],"balance_after":35000,"derivative":{"exercise_price":3.22,"expiration_date":"2032-06-21","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0000899243-22-023990","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1381205/000089924322023990/doc4.xml","form_type":"4"}},{"id":2443009,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":30952,"kind":"person","name":"Kender Richard N","position":1,"cik":"0001381205","reported_name":"Kender Richard N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-01-05T17:22:51.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option is fully vested and exercisable."}],"balance_after":10000,"derivative":{"exercise_price":60.87,"expiration_date":"2032-01-03","underlying":"Ordinary Shares","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-22-001817","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1381205/000120919122001817/doc4.xml","form_type":"4"}},{"id":2443008,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":30952,"kind":"person","name":"Kender Richard N","position":1,"cik":"0001381205","reported_name":"Kender Richard N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2022-01-05T17:22:51.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award.  The RSUs are fully vested."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one ordinary share."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001209191-22-001817","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1381205/000120919122001817/doc4.xml","form_type":"4"}},{"id":2660316,"issuer":{"id":7191,"kind":"organization","name":"Seres Therapeutics, Inc."},"owners":[{"id":30952,"kind":"person","name":"Kender Richard N","position":1,"cik":"0001381205","reported_name":"Kender Richard N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-21T16:30:45.000Z","date":"2021-06-16","kind":"grant","acquired":true,"shares":23000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of June 16, 2022 or the day immediately prior to the company's 2022 annual meeting of shareholders."}],"balance_after":23000,"derivative":{"exercise_price":19.74,"expiration_date":"2031-06-15","underlying":"Common Stock","underlying_shares":23000},"source":{"system":"sec-edgar","filing":"0000899243-21-024990","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1381205/000089924321024990/doc4.xml","form_type":"4"}},{"id":2919249,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":30952,"kind":"person","name":"Kender Richard N","position":1,"cik":"0001381205","reported_name":"Kender Richard N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-01-05T17:39:15.000Z","date":"2021-01-04","kind":"grant","acquired":true,"shares":19000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":19000,"derivative":{"exercise_price":17.95,"exercise_date":"2021-01-04","expiration_date":"2031-01-04","underlying":"Ordinary Shares","underlying_shares":19000},"source":{"system":"sec-edgar","filing":"0001209191-21-001388","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1381205/000120919121001388/doc4.xml","form_type":"4"}},{"id":3102859,"issuer":{"id":7191,"kind":"organization","name":"Seres Therapeutics, Inc."},"owners":[{"id":30952,"kind":"person","name":"Kender Richard N","position":1,"cik":"0001381205","reported_name":"Kender Richard N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-22T16:11:54.000Z","date":"2020-06-18","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of June 18, 2021 or the day immediately prior to the company's 2021 annual meeting of shareholders."}],"balance_after":30000,"derivative":{"exercise_price":4.4,"expiration_date":"2030-06-17","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000899243-20-017354","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1381205/000089924320017354/doc4.xml","form_type":"4"}},{"id":3317612,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":30952,"kind":"person","name":"Kender Richard N","position":1,"cik":"0001381205","reported_name":"Kender Richard N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-01-06T17:12:42.000Z","date":"2020-01-02","kind":"grant","acquired":true,"shares":8202,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest in 36 equal monthly installments at the end of each calendar month following July 18, 2019."}],"balance_after":8202,"derivative":{"exercise_price":9.82,"expiration_date":"2030-01-02","underlying":"Ordinary Shares","underlying_shares":8202},"source":{"system":"sec-edgar","filing":"0001209191-20-002011","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1381205/000120919120002011/doc4.xml","form_type":"4"}},{"id":3317611,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":30952,"kind":"person","name":"Kender Richard N","position":1,"cik":"0001381205","reported_name":"Kender Richard N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-01-06T17:12:42.000Z","date":"2020-01-02","kind":"grant","acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":16000,"derivative":{"exercise_price":9.82,"exercise_date":"2020-01-02","expiration_date":"2030-01-02","underlying":"Ordinary Shares","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001209191-20-002011","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1381205/000120919120002011/doc4.xml","form_type":"4"}},{"id":3404217,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":30952,"kind":"person","name":"Kender Richard N","position":1,"cik":"0001381205","reported_name":"Kender Richard N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-09-30T16:38:13.000Z","date":"2019-09-26","kind":"grant","acquired":true,"shares":23798,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option shall vest in 36 equal monthly installments commencing on July 18, 2019."}],"balance_after":23798,"derivative":{"exercise_price":11.66,"expiration_date":"2029-09-26","underlying":"Ordinary Shares","underlying_shares":23798},"source":{"system":"sec-edgar","filing":"0001209191-19-051101","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1381205/000120919119051101/doc4.xml","form_type":"4"}},{"id":3489269,"issuer":{"id":7191,"kind":"organization","name":"Seres Therapeutics, Inc."},"owners":[{"id":30952,"kind":"person","name":"Kender Richard N","position":1,"cik":"0001381205","reported_name":"Kender Richard N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-06-14T16:10:03.000Z","date":"2019-06-13","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of June 13, 2020 or the day immediately prior to the company's 2020 annual meeting of shareholders."}],"balance_after":15000,"derivative":{"exercise_price":2.83,"expiration_date":"2029-06-12","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000899243-19-017013","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1381205/000089924319017013/doc4.xml","form_type":"4"}},{"id":3882067,"issuer":{"id":7191,"kind":"organization","name":"Seres Therapeutics, Inc."},"owners":[{"id":30952,"kind":"person","name":"Kender Richard N","position":1,"cik":"0001381205","reported_name":"Kender Richard N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-06-27T21:06:14.000Z","date":"2018-06-26","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of June 26, 2019 or the day immediately prior to the company's 2019 annual meeting of shareholders."}],"balance_after":15000,"derivative":{"exercise_price":9.09,"expiration_date":"2028-06-25","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000899243-18-018521","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1381205/000089924318018521/doc4.xml","form_type":"4"}},{"id":4275126,"issuer":{"id":7191,"kind":"organization","name":"Seres Therapeutics, Inc."},"owners":[{"id":30952,"kind":"person","name":"Kender Richard N","position":1,"cik":"0001381205","reported_name":"Kender Richard N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-06-21T17:19:48.000Z","date":"2017-06-20","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of June 20, 2018 or the day immediately prior to the company's 2018 annual meeting of shareholders."}],"balance_after":15000,"derivative":{"exercise_price":11.21,"expiration_date":"2027-06-19","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000899243-17-016865","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1381205/000089924317016865/doc4.xml","form_type":"4"}},{"id":4306094,"issuer":{"id":109360,"kind":"organization","name":"Syneos Health, Inc.","symbol":"SYNH"},"owners":[{"id":30952,"kind":"person","name":"Kender Richard N","position":1,"cik":"0001381205","reported_name":"Kender Richard N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2017-05-24T16:10:09.000Z","date":"2017-05-23","kind":"grant","acquired":true,"shares":2693,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of restricted stock units which vests in full one year from the grant date, subject to continued service on the Issuer's Board of Directors."}],"balance_after":7148,"source":{"system":"sec-edgar","filing":"0001610950-17-000030","document":"wf-form4_149565659238834.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1381205/000161095017000030/wf-form4_149565659238834.xml","form_type":"4"}}]}